Ultrarush versus semirush initiation of insect venom immunotherapy: A randomized controlled trial

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 1, 2012, Pages 162-168

  Brown, Simon G A ^a,b,c   Wiese, Michael D ^a,d   Van Eeden, Pauline ^c   Stone, Shelley F ^c   Chuter, Christine L ^a   Gunner, Jareth ^a   Wanandy, Troy ^a,e   Phillips, Michael ^c   Heddle, Robert J ^f,g  

^a ROYAL HOBART HOSPITAL   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g FLINDERS UNIVERSITY   (Australia)

Author keywords

anaphylaxis; immunotherapy; Insect sting allergy; randomized controlled trial; venom immunotherapy

Indexed keywords

ANT VENOM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADULT; ANT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; INSECT STING; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYRMECIA PILOSULA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMIRUSH IMMUNOTHERAPY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRARUSH IMMUNOTHERAPY;

ADULT; ANIMALS; ANTS; ARTHROPOD VENOMS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84862886467     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.02.022     Document Type: Article

References (20)

1. S.G.A. Brown Clinical features and severity grading of anaphylaxis J Allergy Clin Immunol 114 2004 371 376 (Pubitemid 39119039)
2. R.S. Pumphrey Lessons for management of anaphylaxis from a study of fatal reactions Clin Exp Allergy 30 2000 1144 1150 (Pubitemid 30619768)
3. K.J. Hunt, M.D. Valentine, A.K. Sobotka, A.W. Benton, F.J. Amodio, and L.M. Lichtenstein A controlled trial of immunotherapy in insect hypersensitivity N Engl J Med 299 1978 157 161 (Pubitemid 8396220)
4. S.G.A. Brown, M.D. Wiese, K.E. Blackman, and R.J. Heddle Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial Lancet 361 2003 1001 1006 (Pubitemid 36351369)
5. J.N. Oude Elberink, J.G. De Monchy, S. Van Der Heide, G.H. Guyatt, and A.E. Dubois Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom J Allergy Clin Immunol 110 2002 174 182 (Pubitemid 36132745)
6. D.B. Golden, A. Kagey-Sobotka, P.S. Norman, R.G. Hamilton, and L.M. Lichtenstein Outcomes of allergy to insect stings in children, with and without venom immunotherapy N Engl J Med 351 2004 668 674
7. J. Birnbaum, D. Charpin, and D. Vervloet Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols Clin Exp Allergy 23 1993 226 230 (Pubitemid 23112346)
8. J. Birnbaum, M. Ramadour, A. Magnan, and D. Vervloet Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors Clin Exp Allergy 33 2003 58 64 (Pubitemid 36114908)
9. M.D. Wiese, N.W. Davies, T.K. Chataway, R.W. Milne, S.G.A. Brown, and R.J. Heddle Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy J Pharm Biomed Anal 54 2011 303 310
10. M.D. Wiese, R.W. Milne, N.W. Davies, T.K. Chataway, S.G.A. Brown, and R.J. Heddle Myrmecia pilosula (Jack Jumper) Ant venom: validation of a procedure to standardise an allergy vaccine J Pharm Biomed Anal 46 2008 58 65 (Pubitemid 350216325)
11. P.E. van Eeden, M.D. Wiese, S. Aulfrey, B.J. Hales, S.F. Stone, and S.G.A. Brown Using time-resolved fluorescence to measure serum venom-specific IgE and IgG PLoS One 6 2011 e16741
12. R. Brehler, H. Wolf, B. Kutting, J. Schnitker, and T. Luger Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections J Allergy Clin Immunol 105 2000 1231 1235 (Pubitemid 30418804)
13. A. Roll, G. Hofbauer, B.K. Ballmer-Weber, and P. Schmid-Grendelmeier Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy J Investig Allergol Clin Immunol 16 2006 79 85 (Pubitemid 43807147)
14. M.D. Wiese, S.G.A. Brown, T.K. Chataway, N.W. Davies, R.W. Milne, and S.J. Aulfrey Myrmecia pilosula (Jack Jumper) Ant venom: identification of allergens and revised nomenclature Allergy 62 2007 437 443 (Pubitemid 46398803)
15. M.T. Krishna, P.W. Ewan, L. Diwakar, S.R. Durham, A.J. Frew, and S.C. Leech Diagnosis and management of Hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines Clin Exp Allergy 41 2011 1201 1220
16. G. Sturm, B. Kranke, C. Rudolph, and W. Aberer Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients J Allergy Clin Immunol 110 2002 928 933 (Pubitemid 36005882)
17. F. Rueff, B. Przybilla, M.B. Bilo, U. Muller, F. Scheipl, and W. Aberer Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase J Allergy Clin Immunol 126 2010 105 111.e5
18. C. Ozdemir, U.C. Kucuksezer, M. Akdis, and C.A. Akdis Mechanisms of immunotherapy to wasp and bee venom Clin Exp Allergy 41 2011 1226 1234
19. P.W. van der Linden, C.E. Hack, A. Struyvenberg, and J.K. van der Zwan Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis J Allergy Clin Immunol 94 1994 151 159
20. P.A. Wachholz, and S.R. Durham Induction of 'blocking' IgG antibodies during immunotherapy Clin Exp Allergy 33 2003 1171 1174 (Pubitemid 37108518)